Private market activity in medtech surged in 2025, with both VC and PE deal value reaching multiyear highs. The sector’s strongest companies drove the uptick, as investors consolidated capital in megadeals across both asset classes. On the PE side, Hologic was taken private by Blackstone and TPG in a massive $18.3 billion deal. Additionally, Medline completed one of the largest healthcare public listings in history—showing strong demand for traditional medtech business models even as tariffs remain a headwind.
Read the full article: PitchBook Q4 2025 Medtech VC and PE Trends //
Source: https://pitchbook.com/news/reports/q4-2025-medtech-vc-and-pe-trends